期刊文献+

伴有重度肺动脉高压的结缔组织病合并妊娠死亡临床分析

A retrospective analysis of three deaths with severe pulmonary arterial hypertension associated with connective tissue disease during pregnancy
下载PDF
导出
摘要 目的探讨结缔组织病合并肺动脉高压及妊娠患者的临床特点、诊疗关键。方法本文回顾分析2013—2015年期间我院收治的3例伴有重度肺动脉高压的结缔组织病合并妊娠死亡病例的临床资料。结果 2例基础病为系统性红斑狼疮,1例为混合结缔组织病;3例患者发现肺动脉高压时均合并妊娠,均死亡,1例在妊娠20周死亡,2例产后死亡。死亡原因包括肺动脉高压危象,室性心律失常。结论肺动脉高压是结缔组织病的严重并发症之一,结缔组织病相关肺动脉高压患者一旦妊娠,死亡率高。对此类患者强调早期诊断及教育,避免妊娠,在孕早期及时终止妊娠。 Objective To describe the clinical characteristics and therapy in severe pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) during pregnancy. Method The charts of 3 pregnant women with severe CTD-PAH during 2013--2015 were reviewed to assess the multidisciplinary treatment and outcome of these patients. Result There were 2 cases of systemic lupus erythematosus associated PAH and 1 case of mixed connective tissue associated PAH. These 3 patients first presented with PAH during pregnancy were not rescued successfully. One patient died before delivery at 20 weeks' gestation and two died postpar^rn. The causes of death included pulmonary arterial hypertension crisis and ventricular arrhythmias. Conclusion Pulmonary hypertension is one of the most serious complications of connective tissue disease. Pregnancy in patients with CTD-PAH is associated with a high maternal mortality. Thus, focus should be placed on early diagnosis of CTD-PAH and women with CTD- PAH should be counseled to terminate an early pregnancy or avoid pregnancy.
作者 高飞 林禾 GAO Fei LIN He(Department of Immunology and Rheumatology, Fujian Provincial Hospital, Fuzhou 350001,China)
出处 《创伤与急诊电子杂志》 2016年第3期138-140,共3页 Journal of Trauma and Emergency(Electronic Version)
关键词 高血压 肺性 结缔组织病 妊娠 Hypertension,Pulmonary Connective tissue disease Pregnancy
  • 相关文献

参考文献3

二级参考文献34

  • 1Martinez J, Comas C, Sala X, et al. Materal primary pulmonary arterial hypertension associated with pengnancy. Europ J Obstet Gynaeeol Reprod Biol , 1994,54 : 143-147. 被引量:1
  • 2Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical pratice guidelines. Chest,2004,126Suppl 1:7-10. 被引量:1
  • 3Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coil Cardio1,2004 ,43 :5-12. 被引量:1
  • 4Lieber S, Dewilde PH, Huyghens L, et al. Eisenmenger's syndrome and pregnancy. Acta Cardiol, 1985,40:421-424. 被引量:1
  • 5Heytens L, Alexander JP. Maternal and neonatal death associated with Eisenmenger's syndrome. Acta Anaesthesiol Belg, 1986,37 : 45-51. 被引量:1
  • 6Olschewski H, Simonneau G, Galie N, et al. Inhaled Iloprost for severe pulmonary hypertension. N Engl J Med, 2002,347: 322- 329. 被引量:1
  • 7Elliot CA, Stewart P, Webster VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J, 2005,26 : 168-173. 被引量:1
  • 8Avdalovic M, Sandrock C, Hoso A, et al. Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literature. Treat Respir Med ,2004,3 : 29-34. 被引量:1
  • 9Lam GK, Stafford RE, Thorp J, et al. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol, 2001,98(5 Pt 2) :895-898. 被引量:1
  • 10杨宁,赵成,刘布骏,孙凌云.结缔组织病并发肺动脉高压110例临床分析[J].中华风湿病学杂志,2007,11(9):552-555. 被引量:20

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部